vatalanib has been researched along with Glioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beumer, JH; Desjardins, A; Egorin, MJ; Friedman, HS; Gururangan, S; Herndon, JE; Lagattuta, TF; Reardon, DA; Salvado, AJ; Vredenburgh, JJ | 1 |
| Liu, JM; Tang, GS; Wang, Y; Yue, ZJ; Zhang, H; Zhang, YH | 1 |
| Dai, C; Draghi, N; Eklöf, C; Holland, EC; Liang, X; Resh, MD; Uhrbom, L; Westermark, B; Wolf, RM | 1 |
| Bendszus, M; Goldbrunner, RH; Kiderlen, M; Sasaki, M; Tonn, JC; Wood, J | 1 |
1 trial(s) available for vatalanib and Glioma
| Article | Year |
|---|---|
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Hydroxyurea; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Phthalazines; Piperazines; Pyridines; Pyrimidines; Recurrence; Treatment Outcome | 2009 |
3 other study(ies) available for vatalanib and Glioma
| Article | Year |
|---|---|
Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Disease Models, Animal; Drug Delivery Systems; Glioma; Humans; Lactic Acid; Male; Neovascularization, Pathologic; Phthalazines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyridines; Rats; Rats, Sprague-Dawley; Temozolomide; Treatment Outcome | 2010 |
p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.
Topics: Animals; Brain Neoplasms; Cell Differentiation; Cells, Cultured; Chromosomes, Human, Pair 19; DNA-Binding Proteins; Down-Regulation; Genes, Tumor Suppressor; Glioma; GTPase-Activating Proteins; Guanine Nucleotide Exchange Factors; Humans; Intermediate Filament Proteins; Mice; Mice, Inbred Strains; Nerve Tissue Proteins; Nestin; Nuclear Proteins; Oligodendroglioma; Phthalazines; Platelet-Derived Growth Factor; Pyridines; Repressor Proteins; Retroviridae | 2003 |
PTK787/ZK222584, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decreases glioma growth and vascularization.
Topics: Angiogenesis Inhibitors; Animals; Brain; Brain Neoplasms; Cell Division; Cell Survival; Glioma; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |